Coloma Jason V
SEC insider (Form 3/4/5 filer). CIK 0001676170. Chief Executive Officer at Maze Therapeutics, Inc. (MAZE) and 1 other issuer. 29 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Coloma Jason V has filed insider reports for
- Maze Therapeutics, Inc. (MAZE): Director, Officer, Chief Executive Officer
- Braveheart Bio, Inc. (BRVE): Director
Coloma Jason V
CIK: 0001676170
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (29 total)
- Oct 1, 2026MAZE
Maze Therapeutics, Inc.
SaleIndirect2.6K shares at avg. $27.02$70K - Oct 1, 2026MAZE
Maze Therapeutics, Inc.
SaleIndirect31.9K shares at avg. $27.02$862K - Sep 3, 2026MAZE
Maze Therapeutics, Inc.
SaleDirect129 shares at avg. $25.77$3K - Sep 3, 2026MAZE
Maze Therapeutics, Inc.
SaleDirect11.3K shares at avg. $26.01$293K - Sep 2, 2026MAZE
Maze Therapeutics, Inc.
SaleDirect1.4K shares at avg. $27.12$37K - Sep 2, 2026MAZE
Maze Therapeutics, Inc.
SaleDirect9.9K shares at avg. $26.38$260K - Sep 1, 2026MAZE
Maze Therapeutics, Inc.
SaleIndirect31.9K shares at avg. $26.29$839K - Sep 1, 2026MAZE
Maze Therapeutics, Inc.
ExerciseDirect50K shares- - Sep 1, 2026MAZE
Maze Therapeutics, Inc.
SaleIndirect2.6K shares at avg. $26.31$68K - Aug 3, 2026MAZE
Maze Therapeutics, Inc.
SaleIndirect30.3K shares at avg. $26.71$810K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 |  MAZE Maze Therapeutics, Inc. | Sale | 2,593 | $27.02 | $70,073 | Indirect |
| Oct 1, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 31,908 | $27.02 | $862,186 | Indirect |
| Sep 3, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 129 | $25.77 | $3,325 | Direct |
| Sep 3, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 11,282 | $26.01 | $293,482 | Direct |
| Sep 2, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 1,375 | $27.12 | $37,292 | Direct |
| Sep 2, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 9,852 | $26.38 | $259,856 | Direct |
| Sep 1, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 31,908 | $26.29 | $838,785 | Indirect |
| Sep 1, 2026 | MAZE Maze Therapeutics, Inc. | Exercise | 50,000 | - | $0 | Direct |
| Sep 1, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 2,593 | $26.31 | $68,214 | Indirect |
| Aug 3, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 30,304 | $26.71 | $809,541 | Indirect |
1-10 of 29 transactions